Nektar Therapeutics Stock Plunges on Earnings, Disclosure of Drug Trial Issues - Barron's

Nektar Therapeutics Stock Plunges on Earnings, Disclosure of Drug Trial Issues  Barron's

Shares of biotech firm Nektar Therapeutics collapsed after the company revealed in an earnings call that there had been manufacturing issues in two batches of ...

View full coverage on Google News

from Top stories - Google News https://ift.tt/2YUcKP8
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bill Belichick still reigns supreme, Mac Jones looks a lot like young Brady — Colin | NFL | THE HERD - The Herd with Colin Cowherd

Bill Belichick still reigns supreme, Mac Jones looks a lot like young Brady — Colin | NFL | THE HERD    The Herd with Colin Cowherd Patrio...